지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2014.12
- 수록면
- 248 - 257 (10page)
이용수
초록· 키워드
오류제보하기
Objectives：The purpose of this study was to evaluate the characteristics and the effects of neurofeedback from child and adolescent patients with ADHD in retrospective setting.
Methods：Forty-eight patients who received neurofeedback from a university hospital in Korea from July, 2005 to July, 2010 participated in this study. Twenty-nine patients were placed in medication group, the other 19 patients were placed in no-medication group. Two groups are not statistically different in intelligence, ADHD severity and baseline CGI. The demographic data, characteristics of psychiatric disorders, and states of neurofeedback were analyzed. The effects of neurofeedback were evaluated before and after training using CGI and subjective self-rating scale(The Hill-Castro Checklist).
Results：Twenty-nine patients had been taking medicine, and 13 patients(44.8%) of those patients have been taking medication for less than a year. The average frequency of neurofeedback was 36.1, and neurofeedback protocol was preferred β/SMR(58.3%) for both groups. Significant changes in CGI before and after training were noticed in both groups(＜.001). And self- rating scale also showed significant changes in attention, hyperactivity, impulsivity, immaturity, self- esteem and hostility(＜.001) in medication group and attention, hyperactivity, impulsivity, hostility and aggressive/sadistic behavior in no-medication group. Both medication groups and no-medication group showed significant improvement.
Conclusion：This is a retrospective study in clinical setting, so there are several limitations. But this study demonstrates the significant positive effects of neurofeedback in objective and subjective rating scales for young patients with ADHD. Prospective controlled studies are needed in the future.
Methods：Forty-eight patients who received neurofeedback from a university hospital in Korea from July, 2005 to July, 2010 participated in this study. Twenty-nine patients were placed in medication group, the other 19 patients were placed in no-medication group. Two groups are not statistically different in intelligence, ADHD severity and baseline CGI. The demographic data, characteristics of psychiatric disorders, and states of neurofeedback were analyzed. The effects of neurofeedback were evaluated before and after training using CGI and subjective self-rating scale(The Hill-Castro Checklist).
Results：Twenty-nine patients had been taking medicine, and 13 patients(44.8%) of those patients have been taking medication for less than a year. The average frequency of neurofeedback was 36.1, and neurofeedback protocol was preferred β/SMR(58.3%) for both groups. Significant changes in CGI before and after training were noticed in both groups(＜.001). And self- rating scale also showed significant changes in attention, hyperactivity, impulsivity, immaturity, self- esteem and hostility(＜.001) in medication group and attention, hyperactivity, impulsivity, hostility and aggressive/sadistic behavior in no-medication group. Both medication groups and no-medication group showed significant improvement.
Conclusion：This is a retrospective study in clinical setting, so there are several limitations. But this study demonstrates the significant positive effects of neurofeedback in objective and subjective rating scales for young patients with ADHD. Prospective controlled studies are needed in the future.
목차
서론
대상 및 방법
결과
고찰
참고문헌
참고문헌 (0)
참고문헌 신청이 논문의 저자 정보
이 논문과 함께 이용한 논문
뉴로피드백 훈련이 성장기 아동의 불안정한 뇌파와 비활성뇌파에 미치는 영향과 학습효과
정지혜
,
김정열
,
이성재
한국정신과학회 학술대회논문집
2006
.10
소아청소년 신경증 환자에서 뉴로피드백 효과에 대한 예비연구
채진혁
,
김혜금
,
정진영
외 4명
생물치료정신의학
2014
.08
뉴로피드백을 이용한 뇌기능 최적화 연구-임상사례 중심
박인순
,
박병운
한국정신과학회 학술대회논문집
2003
.04
뉴로피드백 훈련이 Attention-Deficit Hyperactivity Disorder 아동의 실행기능에 미치는 영향
윤석민
,
곽영숙
소아청소년정신의학
2015
.03
최후통첩게임 및 독재자게임을 통한 조현병 환자들의 사회적 의사결정에 관한 연구
추지윤
,
김양태
생물치료정신의학
2014
.08
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2016-513-001023826